Claims
- 1. A 1,2-ethanediol derivative represented by the following formula or a salt thereof: ##STR568## wherein R.sup.1 represents a substituted or unsubstituted phenyl group; R.sup.2 represents a hydrogen atom, a lower alkyl group or a hydroxyl-protecting group; R.sup.3 represents a hydrogen atom or a lower alkyl group; nR.sup.4 's and nR.sup.5 's are the same as or different from one another and represent hydrogen atoms or lower alkyl groups; R.sup.6 represents a substituted or unsubstituted nitrogen-containing heterocyclic group, the nitrogen-containing heterocyclic group being selected from the group consisting of pyrrolyl, pyrrolidinyl, piperidyl, piperazinyl, imidazolyl, pyrazolyl, pyridyl, tetrahydropyridyl, pyrimidinyl, morpholinyl, thiomorpholinyl, quinolyl, quinolizinyl, tetrahydroquinolinyl, tetrahydroisoquinolinyl, quinuclidinyl, thiazolyl, tetrazolyl, thiadiazolyl, pyrrolinyl, imidazolinyl, imidazolidinyl, pyrazolinyl, pyrazolidinyl, purinyl and indazolyl groups; and n represents an integer of 1 to 6, wherein the substituent on R.sup.1 is selected from the group consisting of halogen atoms, substituted or unsubstituted amino, lower alkyl, aryl, ar-lower alkyl, lower alkoxy, ar-lower alkoxy, aryloxy, carbamoyloxy, lower alkylthio, lower alkenyl, lower alkenyloxy, ar-lower alkylthio, ar-lower alkylsulfonyl, arylsulfonyl, lower alkylsulfonylamino, arylsulfonylamino and heterocyclic groups, protected amino groups, protected or unprotected hydroxyl groups, nitro group, and lower alkylenedioxy groups; the substituted lower alkyl, aryl, ar-lower alkyl, lower alkoxy, ar-lower alkoxy, aryloxy, carbamoyloxy, lower alkylthio, lower alkenyl, lower alkenyloxy, ar-lower alkylthio, ar-lower alkylsulfonyl, arylsulfonyl, lower alkylsulfonylamino, arylsulfonylamino or heterocyclic group as the substituent of R.sup.1 and the substituted nitrogen-containing heterocyclic group as R.sup.6 have each at least one substituent selected from the group consisting of halogen atoms, protected or unprotected hydroxyl groups, protected or unprotected amino groups, protected or unprotected carboxyl groups, unsubstituted lower alkyl groups, lower alkyl groups substituted by a protected or unprotected hydroxyl group, unsubstituted or halogen-substituted aryl groups, unsubstituted or halogen-substituted aroyl groups, unsubstituted lower alkoxy groups, lower alkoxy groups substituted by a lower alkoxy group, lower acyl groups, ar-lower alkyl groups, ar-lower alkenyl groups, heterocyclic groups, heterocyclic-CO-groups, oxo group, lower alkylsulfonyl groups and arylsulfonyl groups; and the substituted amino group as the substituent of R.sup.1 has at least one substituent selected from the group consisting of protected or unprotected hydroxyl groups, unsubstituted lower alkyl groups, lower alkyl groups substituted by a protected or unprotected carboxyl or hydroxyl group, cycloalkyl groups, aryl groups, lower acyl groups, ar-lower alkyl groups, heterocyclic groups, unsubstituted or oxo-substituted heterocyclic-CO-- groups, adamantyl group, lower alkylsulfonyl groups and arylsulfonyl groups, provided that there are excluded the compounds in which R.sup.1 is a phenyl group which may optionally be substituted by the halogen atom or the lower alkyl, lower alkylenedioxy, lower alkoxy or protected or unprotected hydroxyl group and R.sup.6 is --NR.sup.7 R.sup.8 in which R.sup.7 and R.sup.8 form, when taken with the N atom, ##STR569## in which R.sup.9 presents an aryl or heterocyclic group and i represents 0 or an integer of 1 to 3, ##STR570## in which R.sup.10 represents an aryl, heterocyclic or ##STR571## heterocyclic group and R.sup.8 and i have the same meanings as defined above, ##STR572## in which R.sup.11 represents an aryl group, ##STR573## in which R.sup.12 represents a carboxyl group or a lower alkoxy-carbonyl group or ##STR574## in which R.sup.12 has the same meaning as defined above, the compound in which R.sup.1 represents an unsubstituted phenyl group and R.sup.6 represents ##STR575## and the compounds in which R.sup.1 represents an unsubstituted or lower alkyl-substituted phenyl group and R.sup.6 represents ##STR576## all the above heterocyclic groups being selected from the group consisting of the nitrogen-containing heterocyclic groups mentioned in the definition of R.sup.6 and furyl, thienyl, benzothienyl, pyranyl, isobenzofuranyl, oxazolyl, benzofuranyl, indolyl, benzimidazolyl, benzoxazolyl, benzothiazolyl, quinoxalyl, dihydroquinoxalyl, 2,3-dihydrobenzothienyl, 2,3-dihydrobenzopyrrolyl, 2,3-dihydro-4H-1-thianaphthyl, 2,3-dihydrobenzofuranyl, benzo�b!dioxanyl, imidazo�2,3-a!pyridyl, benzo�b!piperazinyl, chromenyl, isothiazolyl, isoxazolyl, oxadiazoyl, pyridazinyl, isoindolyl and isoquinolyl groups.
- 2. The 1,2-ethanediol derivative or a salt thereof according to claim 1, wherein R.sup.1 represents a substituted or unsubstituted phenyl group; R.sup.2 represents a hydrogen atom or a hydroxyl-protecting group; nR.sup.4,s are the same as or different from one another and represent hydrogen atoms or lower alkyl groups; nR.sup.5 's represent hydrogen atoms; and R.sup.6 represents a substituted or unsubstituted nitrogen-containing heterocyclic group, the nitrogen-containing heterocyclic group being selected from the group consisting of pyrrolyl, piperazinyl, imidazolyl, pyrazolyl, pyridyl, tetrahydropyridyl, pyrimidinyl, quinolyl, quinolizinyl, tetrahydroquinolinyl, quinuclidinyl, thiazolyl and thiadiazolyl groups.
- 3. A cerebral function-improving agent comprising a 1,2-ethanediol derivative represented by the following formula or a salt thereof: ##STR577## wherein R.sup.1 represents a substituted or unsubstituted phenyl group; R.sup.2 represents a hydrogen atom, a lower alkyl group or a hydroxyl-protecting group; R.sup.3 represents a hydrogen atom or a lower alkyl group; nR.sup.4 's and nR.sup.5 's are the same as or different from one another and represent hydrogen atoms or lower alkyl groups; R.sup.6 represents a substituted or unsubstituted nitrogen-containing heterocyclic group, the nitrogen-containing heterocyclic group being selected from the group consisting of pyrrolyl, pyrrolidinyl, piperidyl, piperazinyl, imidazolyl, pyrazolyl, pyridyl, tetrahydropyridyl, pyrimidinyl, morpholinyl, thiomorpholinyl, quinolyl, quinolizinyl, tetrahydroquinolinyl, tetrahydroisoquinolinyl, quinuclidinyl, thiazolyl, tetrazolyl, thiadiazolyl, pyrrolinyl, imidazolinyl, pyrazolinyl, pyrazolidinyl, purinyl and indazolyl groups; and n represents 0 or an integer of 1 to 6, wherein the substituent on R.sup.1 is selected from the group consisting of halogen atoms, substituted or unsubstituted amino, lower alkyl, aryl, ar-lower alkyl, lower alkoxy, ar-lower alkoxy, aryloxy, carbamoyloxy, lower alkylthio, lower alkenyl, lower alkenyloxy, ar-lower alkylthio, ar-lower alkylsulfonyl, arylsulfonyl, lower alkylsulfonylamino, arylsulfonylamino and heterocyclic groups, protected amino groups, protected or unprotected hydroxyl groups, nitro group and lower alkylenedioxy groups; the substituted lower alkyl, aryl, ar-lower alkyl, lower alkoxy, ar-lower alkoxy, aryloxy, carbamoyloxy, lower alkylthio, lower alkenyl, lower alkenyloxy, ar-lower alkylthio, ar-lower alkylsulfonyl, arylsulfonyl, lower alkylsulfonylamino, arylsulfonylamino or heterocyclic group as the substituent of R.sup.1 and the substituted nitrogen-containing heterocyclic group as R.sup.6 have each at least one substituent selected from group consisting of halogen atoms, protected or unprotected hydroxyl groups, protected or unprotected amino groups, protected or unprotected carboxyl groups, unsubstituted lower alkyl groups, lower alkyl groups substituted by a protected or unprotected hydroxyl group, unsubstituted or halogen-substituted aryl groups, unsubstituted or halogen-substituted aroyl groups, unsubstituted alkoxy groups, lower alkoxy groups substituted by a lower alkoxy group, lower acyl groups, ar-lower alkyl groups, ar-lower alkenyl groups, heterocyclic groups, heterocyclic-CO-- groups, oxo group, lower alkylsulfonyl groups and arylsulfonyl groups; and the substituted amino group as the substituent of R.sup.1 has at least one substituent selected from the group consisting of protected or unprotected hydroxyl groups, unsubstituted lower alkyl groups, lower alkyl groups substituted by a protected or unprotected carboxyl or hydroxyl group, cycloalkyl groups, aryl groups, lower acyl groups, ar-lower alkyl groups, heterocyclic groups, unsubstituted or oxo-substituted heterocyclic-CO-- groups, adamantyl group, lower alkylsulfonyl groups and arylsulfonyl groups, provided that there are excluded the compounds in which R.sup.1 is a phenyl group which may optionally be substituted by the halogen atom or the lower alkyl, lower alkylenedioxy, lower alkoxy or protected or unprotected hydroxyl group and R.sup.6 is --NR.sup.7 R.sup.8 in which R.sup.7 and R.sup.8 form, when taken with the N atom, ##STR578## in which R.sup.9 represents an aryl or heterocyclic group and i represents 0 or an integer of 1 to 3, ##STR579## in which R.sup.10 represents an aryl, heterocyclic or ##STR580## heterocyclic group and R.sup.8 and i have the same meanings as defined above, ##STR581## in which R.sup.11 represents an aryl group, ##STR582## in which R.sup.12 represents a carboxyl group or a lower alkoxy-carbonyl group or ##STR583## in which R.sup.12 has the same meaning as defined above; all the above heterocyclic groups being selected from the group consisting of the nitrogen-containing heterocyclic groups mentioned in the definition of R.sup.6 and furyl, thienyl, benzothienyl, pyranyl, isobenzofuranyl, oxazolyl, benzofuranyl, indolyl, benzimidazolyl, benzoxazolyl, benzothiazolyl, quinoxalyl, dihydroquinoxalyl, 2,3-dihydrobenzothienyl, 2,3-dihydrobenzopyrrolyl, 2,3-dihydro-4H-1-thianaphthyl, 2,3-dihydrobenzofuranyl, benzo�b!dioxanyl, imidazo�2,3-a!pyridyl, benzo�b!piperazinyl, chromenyl, isothiazolyl, isoxazolyl, oxadiazoyl, pyridazinyl, isoindolyl and isoquinolyl groups; in combination with a pharmaceutically acceptable inert excipient diluent or carrier.
- 4. A method of treating cerebrovascular dementia, senile dementia, Alzheimer's dementia, sequelae of ischemic encephalopathy or cerebral apoplexy in a patient, comprising:
- administering to said patient a drug containing a 1,2-ethanediol derivative represented by the following formula or a salt thereof: ##STR584## wherein R.sup.1 represents a substituted or unsubstituted phenyl group; R.sup.2 represents a hydrogen atom, a lower alkyl group or a hydroxyl-protecting group; R.sup.3 represents a hydrogen atom or a lower alkyl group: nR.sup.4 's and nR.sup.5 's are the same as or different from one another and represent hydrogen atoms or lower alkyl groups; R.sup.6 represents a substituted or unsubstituted nitrogen-containing heterocyclic group, the nitrogen-containing heterocyclic group being selected from the group consisting of pyrrolyl, pyrrolidinyl, piperidyl, piperazinyl, imidazolyl, pyrazolyl, pyridyl, tetrahydropyridyl, pyrimidinyl, morpholinyl, thiomorphorinyl, quinolyl, quinolizinyl, tetrahydroquinolinyl, tetrahydroisoquinolinyl, quinuclidinyl, thiazolyl, tetrazolyl, thiadiazolyl, pyrrolinyl, imidazolinyl, imidazolidinyl, pyrazolinyl, pyrazolidinyl, purinyl and indazolyl groups; and n represents 0 or an integer of 1 to 6, wherein the substituent on R.sup.1 is selected from the group consisting of halogen atoms, substituted or unsubstituted amino, lower alkyl, aryl, ar-lower alkyl, lower alkoxy, ar-lower alkoxy, aryloxy, carbamoyloxy, lower alkylthio, lower alkenyl, lower alkenyloxy, ar-lower alkylthio, ar-lower alkylsulfonyl, arylsulfonyl, lower alkylsulfonylamino, arylsulfonylamino and heterocyclic groups, protected amino groups, protected or unprotected hydroxyl groups, nitro group and lower alkylenedioxy groups; the substituted lower alkyl, aryl, ar-lower alkyl, lower alkoxy, ar-lower alkoxy, aryloxy, carbamoyloxy, lower alkylthio, lower alkenyl, lower alkenyloxy, ar-lower alkylthio, ar-lower alkylsulfonyl, arylsulfonyl, lower alkylsulfonylamino, arylsulfonylamino or heterocyclic group as the substituent of R.sup.1 and the substituted nitrogen-containing heterocyclic group as R.sup.6 have each at least one substituent selected from group consisting of halogen atoms, protected or unprotected hydroxyl groups, protected or unprotected amino groups, protected or unprotected carboxyl groups, unsubstituted lower alkyl groups, lower alkyl groups substituted by a protected or unprotected hydroxyl group, unsubstituted or halogen-substituted aryl groups, unsubstituted or halogen-substituted aroyl groups, unsubstituted lower alkoxy groups, lower alkoxy groups substituted by a lower alkoxy group, lower acyl groups, ar-lower alkyl groups, ar-lower alkenyl groups, heterocyclic groups, heterocyclic-CO-groups, oxo group, lower alkylsulfonyl groups and arylsulfonyl groups; and the substituted amino group as the substituent of R.sup.1 has at least one substituent selected from the group consisting of protected or unprotected hydroxyl groups, unsubstituted lower alkyl groups, lower alkyl groups substituted by a protected or unprotected carboxyl or hydroxyl group, cycloalkyl groups, aryl groups, lower acyl groups, ar-lower alkyl groups, heterocyclic groups, unsubstituted or oxo-substituted heterocyclic-CO-- groups, adamantyl group, lower alkylsulfonyl groups and arylsulfonyl groups, provided that there are excluded the compounds in which R.sup.1 is a phenyl group which may optionally be substituted by the halogen atom or the lower alkyl, lower alkylenedioxy, lower alkoxy or protected or unprotected hydroxyl group and R.sup.6 is --NR.sup.7 R.sup.8 in which R.sup.7 and R.sup.8 form, when taken with the N atom, ##STR585## in which R.sup.9 represents an aryl or heterocyclic group and i represents 0 or an integer of 1 to 3, ##STR586## in which R.sup.10 represents an aryl, heterocyclic or ##STR587## heterocyclic group and R.sup.8 and i have the same meanings as defined above, ##STR588## in which R.sup.11 represents an aryl group, ##STR589## in which R.sup.12 represents a carboxyl group or a lower alkoxycarbonyl group or ##STR590## in which R.sup.12 has the same meaning as defined above; all the above heterocyclic groups being selected from the group consisting of the nitrogen-containing heterocyclic groups mentioned in the definition of R.sup.6 and furyl, thienyl, benzothienyl, pyranyl, isobenzofuranyl, oxazolyl, benzofuranyl, indolyl, benzimidazolyl, benzoxazolyl, benzothiazolyl, quinoxalyl, dihydroquinoxalyl, 2,3-dihydrobenzothienyl, 2,3-dihydrobenzopyrrolyl, 2,3-dihydro-4H-1-thianaphthyl, 2,3-dihydrobenzofuranyl, benzo�b!dioxanyl, imidazo�2,3-a!pyridyl, benzo�b!piperazinyl, chromenyl, isothiazolyl, isoxazolyl, oxadiazoyl, pyridazinyl, isoindolyl and isoquinolyl groups.
- 5. The method according to claim 4, wherein R.sup.1 represents a substituted or unsubstituted phenyl group; R.sup.2 represents a hydrogen atom or a hydroxyl-protecting group; nR.sup.4 's are the same as or different from one another and represent hydrogen atoms or lower alkyl groups; nR.sup.5 's represent hydrogen atoms; and R.sup.6 represents a substituted or unsubstituted nitrogen-containing heterocyclic group, the nitrogen-containing heterocyclic group being selected from the group consisting of pyrrolyl, pyrrolidinyl, piperidinyl, piperazinyl, imidazolyl, pyrazolyl, pyridyl, tetrahydropyridyl, pyrimidinyl, morpholinyl, quinolyl, quinolizinyl, tetrahydroquinolinyl, quinuclidinyl, thiazolyl and thiadiazolyl groups.
- 6. The method according to claim 4, wherein R.sup.1 represents the substituted or unsubstituted phenyl group; R.sup.6 represents a substituted or unsubstituted nitrogen-containing heterocyclic group, the nitrogen-containing heterocyclic group being selected from the group consisting of pyrrolinyl, piperidyl, piperazinyl, imidazolyl, pyridyl, morpholinyl, thiomorpholinyl, tetrahydropyridyl, quinuclidinyl and tetrazolyl, the substituent on R.sup.1 is selected from the group consisting of halogen atoms; lower alkyl groups; lower alkenyl groups; phenyl groups which may optionally be substituted by a halogen atom or a lower alkyl or lower alkoxy group; phenyl-C.sub.1-4 -alkyl groups; lower alkoxy groups which may optionally be substituted by a pyridyl, furyl or thienyl group; phenyl-C.sub.1-4 -alkoxy groups which may optionally be substituted by a halogen atom or a lower alkyl, hydroxyl or lower alkoxy group; a phenoxy group; phenylaminocarbonyloxy groups which may optionally be substituted by a halogen atom; lower alkylaminocarbonyloxy groups; lower alkylthio groups; a phenylsulfonylamino group; amino groups which may optionally be substituted by a lower alkyl group; a hydroxyl group; a nitro group; phenyl-C.sub.1-4 -alkylthio groups; phenyl-C.sub.1-4 -alkylsulfonyl groups; a thienyl group; a pyridyl group; and lower alkylenedioxy groups; and the substituent on R.sup.6, when R.sup.6 is a substituted nitrogen-containing heterocyclic group, is selected from the group consisting of halogen atoms; a hydroxyl group; lower alkyl groups which may optionally be substituted by a hydroxyl group; an amino group; lower acyl groups which may optionally be substituted by a pyrrolidinyl group; phenyl-C.sub.1-4 -alkyl groups; phenyl-C.sub.2-4 -alkenyl groups; aroyl groups which are substituted by a halogen atom; a pyridyl group and an oxo group; provided that there are excluded the compounds in which R.sup.1 is a phenyl group which may optionally be substituted by the halogen atom or the lower alkyl, lower alkoxy, lower alkylenedioxy or hydroxyl group and R.sup.6 is --NR.sup.7 R.sup.8 in which R.sup.7 and R.sup.8 form, when taken with the N atom, ##STR591## in which R.sup.9 represents a phenyl group and i represents 0 or an integer of 1 to 3.
- 7. The method according to claim 6, wherein R.sup.1 represents a phenyl group which may optionally be substituted by a halogen atom; a phenyl-C.sub.1-4 alkyl group; a phenyl group; a thienyl group; a phenoxy group which may optionally be substituted by a halogen atom or a lower alkoxy group; or a lower alkoxy group which may optionally be substituted by a thienyl group; R.sup.2 represents a hydrogen atom; R.sup.3 represents a hydrogen atom; nR.sup.4,s and nR.sup.5 's represent hydrogen atoms; R.sup.6 represents a morpholinyl group, a pyridyl group, an imidazolyl group which may optionally be substituted by a lower alkyl.
Priority Claims (6)
Number |
Date |
Country |
Kind |
1-032714 |
Feb 1989 |
JPX |
|
1-068958 |
Mar 1989 |
JPX |
|
1-106187 |
Apr 1989 |
JPX |
|
2-24501 |
Feb 1990 |
JPX |
|
2-24502 |
Feb 1990 |
JPX |
|
2-24503 |
Feb 1990 |
JPX |
|
Parent Case Info
This is a Division of application Ser. No. 08/749,143 filed on Nov. 14, 1996, now U.S. Pat. No. 5,719,150, which is a division of application Ser. No. 08/478,810 filed on Jun. 7, 1995, now U.S. Pat. No. 5,612,381, which is a division of application Ser. No. 08/174,793, filed on Dec. 29, 1993, now U.S. Pat. No. 5,472,984, which is a division of application Ser. No. 07/940,747 filed on Sep. 8, 1992, now U.S. Pat. No. 5,280,032, which is a continuation of application Ser. No. 07/566,889 filed on Aug. 14, 1990, abandoned, which is a continuation-in-part of application Ser. No. 07/480,114 filed on Feb. 14, 1990, abandoned.
US Referenced Citations (5)
Non-Patent Literature Citations (5)
Entry |
Yu Zhdanov et al. Chemical Abstracts, 109:129471c. Nucleophilic opening of the carbohydrate oxirane ring under conditions of phase transfer catalysis, vol. 109, No. 15, Oct. 10, 1988. |
Moschel et al., J. Org. Chem., vol. 52, pp. 2952-2955, 1986. |
Baker, J. Org. Chem., vol. 50, pp. 3942-3943, 1985. |
Baiocchi et al., Rend. Accad. Nat., vol. 40, pp. 269-280, 1968. |
Wnterfeld et al., Arch. der Pharmazie, vol. 296, pp. 38-47, 1963. |
Divisions (4)
|
Number |
Date |
Country |
Parent |
749143 |
Nov 1996 |
|
Parent |
478810 |
Jun 1995 |
|
Parent |
174793 |
Dec 1993 |
|
Parent |
940747 |
Sep 1992 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
566889 |
Aug 1990 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
480114 |
Feb 1990 |
|